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Frutalin is the alpha-D-galactose-binding Jacalin-related lectin from Artocarpus incisa seeds. 
One of the most interesting biological properties of frutalin is its potential use in cancer 
diagnosis and therapy due to its ability to bind carbohydrate complexes expressed in cancer 
cells membranes. It can be potentially used as a histochemical probe in the diagnostic of 
several cancers. However, frutalin extraction from seeds is a long process with low yields 
and typically, a heterogeneous mixture with several isolectins is obtained. To improve and 
facilitate the availability of frutalin, its codifying gene was cloned and expressed in Pichia 
pastoris [1] (yeast), Escherichia coli (bacteria) and baculovirus/insect cells system (Sf9 cells 
line). Recombinant frutalin was detected in cultures of all the different organisms by Western 
blot analysis. Molecular differences were found between each recombinant frutalin obtained 
and native frutalin. Optimisation of recombinant frutalin expression and purification was 
conducted for the P. pastoris and E. coli systems. Recombinant yeast frutalin specifically 
bound to Me--galactose and was able to differentiate malign from benign prostate diseases 
in immunohistochemical studies of prostate tissues removed from patients by surgery, 
highlighting the potential applications of the recombinant frutalin in cancer diagnosis. In 
addition, the effect of native and recombinant yeast frutalin on the proliferation of human 
cancer cell lines was investigated. Preliminary results show a potent inhibitory effect of 
frutalin on proliferation in two different cell lines suggesting that it deserves study as a 
potential anticancer agent.  
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